文献速递先天性心脏病外科心外重症与机械循环支持

儿童心脏移植中持续性肾功能不全的相关因素及影响

Associated Factors and Impact of Persistent Renal Dysfunction in Pediatric Heart Transplantation.
PubMed 文献 · Ann Thorac Surg · 2023-01-10

基于美国器官共享联合网络 registry 的 11,625 例儿童心脏移植候选者(2000-2020 年),13% 在登记时存在显著肾功能不全(SRD),SRD 与等待期死亡风险升高(HR 3.016)和移植率降低相关;移植时 47% 的 SRD 患儿肾功能持续不全,持续性 SRD 与移植后 8 年生存率降低相关,而同期心肾联合移植可中和该影响。

要点

  • 登记时 SRD 与等待期死亡风险升高相关(HR 3.016,P < .0001)。
  • SRD 患儿中 47% 在移植时仍有持续性肾功能不全。
  • 持续性 SRD 者移植后 8 年生存率 56%,同期心肾联合移植者为 70%。

核心结论

  • SRD 与等待期死亡风险高和移植率降低相关。
  • 移植前及时适当的 VAD 支持可能促进肾功能恢复。
  • 同期心肾联合移植中和了持续性 SRD 对生存的影响,作者认为可考虑用于透析、机械通气或 ECMO 支持等高危患者。

研究设计与样本

  • 查询美国器官共享联合网络 registry,纳入 2000 至 2020 年登记的 11,625 例儿童心脏移植候选者。
  • SRD 定义为估算肾小球滤过率 <45 mL/min/1.73 m2 和/或需要透析;登记时 1,494 例(13%)存在 SRD。
  • 比较有无 SRD 患儿的特征,分析 SRD 对结局的影响,并评估与等待期死亡、移植时持续性 SRD 及移植后生存(含同期心肾联合移植)相关的因素。

主要发现

  • 与估算肾小球滤过率 >45 mL/min/1.73 m2 的儿童相比,SRD 患儿等待期死亡率更高(37% vs 14%,P < .01),移植率更低(51% vs 71%,P < .01)。
  • 多变量分析中,SRD 与等待期死亡相关(风险比 3.016,P < .0001)。
  • 767 例接受心脏移植的 SRD 患儿中,361 例(47%)在移植时存在持续性 SRD。
  • 多变量分析中,与持续性 SRD 相关的因素包括:年龄较大(每岁 OR 1.147,95% CI 1.046-1.258,P = .0035)、胆红素(每 1-mg/dL OR 1.127,95% CI 1.061-1.197,P < .0001)、透析(OR 1.839,95% CI 1.017-3.326,P = .0115)、机械通气(OR 1.972,95% CI 1.336-2.911,P = .0006)、体外膜氧合(OR 1.747,95% CI 1.074-2.842,P = .0247)以及未使用心室辅助装置(VAD)(VAD 使用 OR 0.498,95% CI 0.277-0.895,P = .0198)。
  • 移植后 8 年生存率分别为:单纯心脏移植且肾功能改善者 72%,同期心肾联合移植者(n = 69)70%,单纯心脏移植且持续性 SRD 者 56%(P < .01)。

临床怎么用

  • 作者认为移植前及时适当的 VAD 支持可能促进肾功能恢复。
  • 作者认为同期心肾联合移植中和了持续性 SRD 对生存的影响,可考虑用于透析、机械通气或 ECMO 支持等高危患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We evaluated the impact of significant renal dysfunction (SRD) on listing and pediatric heart transplantation (PHT) outcomes. METHODS: The United Network of Organ Sharing registry was queried. Our cohort included 11,625 children listed for PHT (2000-2020). At listing, 1494 (13%) had SRD, defined as an estimated glomerular filtration rate of <45 mL/min/1.73 m2 and/or dialysis requirement. Characteristics of children with and without SRD were compared. SRD impact on outcomes was examined. Factors associated with waiting list mortality, persistent SRD at PHT, and post-PHT survival with and without simultaneous heart-kidney transplantation were assessed. RESULTS: Compared with children with an estimated glomerular filtration rate >45 mL/min/1.73 m2, those with SRD had higher waiting list death (37% vs 14%, P < .01) and lower transplantation rate (51% vs 71%, P < .01). On multivariable analysis, SRD was associated with waiting list death (hazard ratio, 3.016; P < .0001). Among 767 children with SRD who received PHT, 361 (47%) had persistent SRD at the time of PHT. On multivariable analysis, factors associated with persistent SRD were older age (odds ratio [OR], 1.147 per year; 95% CI, 1.046-1.258 per year; P = .0035), bilirubin (OR, 1.127 per 1-mg/dL; 95% CI, 1.061-1.197 per 1-mg/dL; P < .0001), dialysis (OR, 1.839; 95% CI, 1.017-3.326; P = .0115), mechanical ventilation (OR, 1.972; 95% CI, 1.336-2.911; P = .0006), extracorporeal membrane oxygenation (OR, 1.747; 95% CI, 1.074-2.842; P = .0247), and not using a ventricular assist device (VAD) (OR, 0.498 [VAD use]; 95% CI, 0.277-0.895 VAD use; P = .0198). Post-PHT survival was 72%, 70%, and 56% (P < .01) at 8 years for PHT alone with improved renal function, simultaneous heart-kidney transplantation (n = 69), and PHT alone with persistent SRD, respectively. CONCLUSIONS: SRD is associated with high waiting list death and decreased transplantation rate. Timely proper pre-PHT support with VAD could enhance kidney recovery. Simultaneous heart-kidney transplantation neutralized persistent SRD effect on survival and might be considered in high-risk patients such as those on dialysis, mechanical ventilation, or extracorporeal membrane oxygenation support.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Alsoufi B, Kozik D, Lambert AN, et al. Associated Factors and Impact of Persistent Renal Dysfunction in Pediatric Heart Transplantation. Ann Thorac Surg. 2023. PMID: 36634833. doi:10.1016/j.athoracsur.2023.01.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。